Data for: Enhanced antitumor effects of CD123/CD33 dual-antibody modified liposome targeting to acute myeloid leukemia cells with reduced the antigen-negative escape
Published: 18 July 2019| Version 1 | DOI: 10.17632/6phjx8s467.1
Contributor:
ShengJun MaoDescription
A dual-targeting drug delivery system was developoed to enhance the therapeutic efficacy of chemotherapeutics and reduce the antigen-negative escape for Acute myeloid leukemia.
Files
Categories
Drug Delivery, Pharmaceutics, Acute Leukemia